Fundamental aspects of DMPK optimization of targeted protein degraders
Year: 2020
Type: review
Source: Drug Discovery Today
Institutions: F. Hoffmann-La Roche AG, C4 Therapeutics (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3016362891
